Antiphospholipid Antibody Induced by Nivolumab

Autor: Aburahma, Ahmed, Aljariri Alhesan, Nour, Elounais, Farah, Abu Sitta, Emad

Publikováno v: Case Reports in Hematology.

Nivolumab is a monoclonal antibody against the programmed death protein 1 and is used for patients with advanced melanoma. It is associated with potentially immune-related adverse events, including disorders of the skin, GI tract, and the thyroid; th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::e898e2b6940028a1d1e7f7ced4a846e1

Ventricular tachycardia after initiation of fingolimod.

Autor: Elounais, Farah, Aburahma, Ahmed, Alkotob, Mohammad Luay, Al Hadidi, Samer

Publikováno v: BMJ Case Reports; 9/27/2017, Vol. 2017, p1-2, 2p, 2 Graphs

A case report of double negative anti-GBM disease.

Autor: Kheiri B; Internal Medicine Department, Hurley Medical Center/Michigan State University, Flint, MI, USA., Osman M; Internal Medicine Department, Hurley Medical Center/Michigan State University, Flint, MI, USA., Elounais F; Internal Medicine Department, Hurley Medical Center/Michigan State University, Flint, MI, USA., Alnimer Y; Internal Medicine Department, Hurley Medical Center/Michigan State University, Flint, MI, USA., Owda AK; Department of Nephrology, Hurley Medical Center/Michigan State University, Flint, MI, USA., Modawi I; Department of Nephrology, Hurley Medical Center/Michigan State University, Flint, MI, USA., Towfiq B; Internal Medicine Department, Hurley Medical Center/Michigan State University, Flint, MI, USA.

Publikováno v: Oxford medical case reports [Oxf Med Case Reports] 2019 Apr 29; Vol. 2019 (4), pp. omy124. Date of Electronic Publication: 2019 Apr 29 (Print Publication: 2019).